Northern Netherlands Region grant for Prof. Quax
Prof. Wim Quax from the Groningen Research Institute of Pharmacy (GRIP) has received a grant worth EUR 200,000 from the Northern Netherlands Region (Samenwerkingsverband Noord-Nederland). Prof. Quax receives this grant for his project ‘Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2’. With this project, he aims to investigate a possible treatment of corona with hesperidin.
This flavonoid has been suggested to block the connection between the SARS-CoV-2 virus and the ACE2 receptor of human cells. The group of Prof. Quax will analyze how hesperidin reduces the affinity of the spike protein for its target, the ACE2 receptor. Hesperidin is a cheap by-product of citrus fruits and has been used safely in humans for years. Together with project partner Color&Brain, alternative delivery routes and their effects on virus binding will be investigated.
Last modified: | 01 July 2020 1.31 p.m. |
More news
-
17 July 2024
Veni-grants for ten researchers in Groningen
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
15 July 2024
Funding for RUG researchers from National Growth Fund programme Circular Plastics NL
For research on making plastics circular, Professors Patrizio Raffa and Katja Loos together receive about 1.2 million euros from the National Growth Fund programme Circular Plastics NL.
-
09 July 2024
NWO Open Technology funding for improving quality 3D printing technology
Dr. Liangliang Cheng receives a NWO OPT grant of EUR 950,000 for research on safer application of metals in 3D printing technology.